TRANSTHERA-B(02617): Sun Delong appointed as Chief Operating Officer.
Pharmalead (02617) announced that Mr. Sun Delong has been appointed as the Chief Operating Officer of the company by the Board of Directors, effective from June 12, 2026. In this position, Mr. Sun will be responsible for all commercial operations of the company. With over twenty years of rich experience in the biopharmaceutical industry, Mr. Sun possesses end-to-end management capabilities, from frontline drug marketing and academic promotion to comprehensive corporate operations.
TRANSTHERA-B (02617) announced that Mr. Sun Delong has been appointed as the Chief Operating Officer of the company by the board of directors, effective from June 12, 2026. In this role, Mr. Sun will be responsible for overseeing all commercial operations of the company. With over twenty years of experience in the biopharmaceutical industry, Mr. Sun possesses a comprehensive management ability that spans from frontline drug marketing and academic promotion to overall corporate operations.
Related Articles
Buying low on Shenzhen Hepalink Pharmaceutical Group (09989) for two consecutive months, will the Hong Kong Stock Connect funds soon witness the reversal of the heparin cycle?
New Stock News | Leading supply chain company Andes Zhilian's Hong Kong IPO prospectus updated, achieving double high increase in revenue and net profit.
How strong is the demand for SpaceX (SPCX.US) IPO? Oversubscribed subscriptions, "greenshoe" exemption from commission, and options expected to open next week!
Buying low on Shenzhen Hepalink Pharmaceutical Group (09989) for two consecutive months, will the Hong Kong Stock Connect funds soon witness the reversal of the heparin cycle?
New Stock News | Leading supply chain company Andes Zhilian's Hong Kong IPO prospectus updated, achieving double high increase in revenue and net profit.
How strong is the demand for SpaceX (SPCX.US) IPO? Oversubscribed subscriptions, "greenshoe" exemption from commission, and options expected to open next week!
RECOMMEND
